ArticleNature communications2026
Improving protein and protein interactions using pseudo-dimers derived from monomeric proteins.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurately predicting protein-protein interactions (PPIs) in dimeric complexes remains a fundamental challenge in computational biology. Although existing PPIs prediction models, such as AlphaFold-Multimer (AF-Multimer) and AlphaFold3 (AF3), have achieved impressive performance, they still suffer from unsatisfactory accuracy due to the limited availability of protein dimer structures, whose collection is both expensive and labor-intensive. Here, we introduce a simple yet effective pre-training method, termed split and merge proxy (SMP), that leverages abundant monomeric proteins to simulate various PPIs tasks for the first time. Specifically, SMP constructs pseudo-dimers by splitting monomer data into two subunits, referred to as pseudo-receptors and pseudo-ligands, and trains models to merge them back by predicting their pseudo interactions (e.g., contact or docking). This proxy task enables large-scale pre-training without additional cost. Models pre-trained with SMP and subsequently fine-tuned on real protein dimer datasets demonstrate consistently improved accuracy and generalization across multiple benchmarks, surpassing strong baselines. Notably, SMP delivers more accurate structure predictions than both AF-Multimer and AF3 on several CASP15 dimer targets. Our findings highlight SMP as a scalable strategy for harnessing monomeric data to advance protein complex modeling, providing insights into the linkage between monomers and multimers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.